leisure time -WSS

leisure time

author：focus 2025-09-06 04:12:44 - browse：1

Blue CAR-T cell attacks a leukemia cell. --health coverage from STAT — Engineered receptors on the surface of a T-lymphocyte bind to a leukemia cell. Adobe

The announcement on Tuesday that the Food and Drug Administration was investigating whether CAR-T immunotherapy had itself caused blood cancers initially appeared to be a significant blow to one of the brightest spots in cancer care.

But experts quickly cautioned that risk of this complication is probably minuscule compared to the known risk of secondary cancers from other cancer therapies like chemotherapy and radiation. They noted that CAR-T cells are immune cells that are genetically engineered to fight cancer, and that such genetic modifications were long thought to carry a risk of causing a second, new cancer in patients. The surprise, in a way, is that since CAR-T was first invented more than 10 years ago, that risk had remained just theoretical.

“There’s been a requirement for long-term follow up. I think this is why we’re all surprised. As far as I think any one of us knew, it’d never happened with any of the FDA-approved CAR-Ts,” said Marcela Maus, a cell therapy researcher at Mass General Cancer Center.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Continuity nursing helped my family in our darkest PICU moments
Next article： With fresh data, a dynamic duo powers Eli Lilly to new heights

explore

WSS

As AI regulations shape up, health tech startups beg for clarity

What to know about a major upcoming Wegovy heart health study

FDA warns medical device makers about rise in fabricated data

FDA warns medical device makers about rise in fabricated data

Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech

Hospitals are piloting generative AI tools as regulators play catch

hotspot

leisure time

knowledge

BioMarin wins approval for gene therapy to treat hemophilia A

Florida group launches initiative to get abortion constitutional amendment on 2024 ballot

In age of alternative facts, a scholarly course on calling out crap

MD Anderson's Padmanee Sharma responds to research credit suit

As demand for Covid shots wanes, Moderna seeks its next success

Trump seeks lengthy delay of classified docs trial, citing upcoming election

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

New study raises questions about niacin and heart health

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Medicare Advantage enrollment grows 7.1% to 33.4 million people

leisure time

Father who lunged at Larry Nassar comforted by deputy who pinned him down: 'I understand'

Flagship Pioneering startup Sonata Therapeutics lays off 21

House panel to mark up pandemic

Tennessee woman gets emergency hysterectomy after doctors deny early abortion care

Medicare Advantage enrollment hits roughly 33.4 million

Another man arrested in connection with shooting at Kansas nightclub

explore

knowledge

knowledge

focus